data_1tit_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tit _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.184 0.516 . . . . 3.2200000000000002 110.164 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.97 HG21 ' CB ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -122.29 -177.72 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 3.3500000000000001 110.172 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -132.92 -161.33 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 3.7999999999999998 110.285 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 78' ' ' ALA . 28.5 t -122.67 91.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 1.6399999999999999 110.196 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 2.2 mm-40 -56.25 -34.53 66.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.269 -0.895 . . . . 2.4199999999999999 110.363 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -130.82 113.76 16.43 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 3.21 110.264 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.55 -176.01 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.557 . . . . 0.76000000000000001 110.407 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.98 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 27.5 mt -86.35 -169.34 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 1.1000000000000001 110.359 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.98 ' HD1' ' O ' ' A' ' 8' ' ' LEU . 2.9 m-85 -146.99 127.93 14.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 4.8200000000000003 110.336 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.906 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.96 127.76 33.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.407 -1.477 . . . . 1.3100000000000001 109.407 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 11' ' ' VAL . 4.0 p -132.5 151.6 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 2.0899999999999999 110.424 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -104.03 161.08 14.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 2.3300000000000001 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -156.14 146.64 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.352 -0.842 . . . . 2.21 110.299 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.765 ' O ' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -97.9 74.88 2.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 2.46 110.211 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.765 ' O ' ' O ' ' A' ' 14' ' ' PHE . 85.6 t 22.15 107.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 1.8799999999999999 110.12 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.974 ' HA2' ' HB2' ' A' ' 62' ' ' ASN . . . 118.51 -38.69 2.8 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.698 -1.361 . . . . 1.1299999999999999 109.698 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.756 ' OE1' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -59.66 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 2.4900000000000002 110.164 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -147.0 117.23 7.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 1.8 110.204 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -80.25 161.97 24.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 1.3600000000000001 110.027 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.92 131.87 31.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 3.3399999999999999 110.598 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.869 ' HB3' ' HZ3' ' A' ' 34' ' ' TRP . 84.2 m-85 -136.62 116.79 13.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 2.2999999999999998 110.056 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -113.12 159.18 19.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.213 -0.929 . . . . 2.0600000000000001 110.679 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 23' ' ' ILE . 4.6 tt -169.74 119.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 1.46 110.039 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.673 ' OE2' ' HE2' ' A' ' 55' ' ' LYS . 2.1 tt0 -97.68 143.46 28.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 2.3799999999999999 110.441 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.779 HD13 ' CD2' ' A' ' 56' ' ' HIS . 17.3 mt -105.34 -146.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 1.97 110.101 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.97 ' CB ' HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -125.47 -35.51 2.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.73 110.326 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.61 ' HG3' ' CG2' ' A' ' 2' ' ' ILE . 46.5 mt-10 -123.75 136.34 27.24 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 3.0600000000000001 110.352 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.686 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 45.0 Cg_endo -73.64 -173.94 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.063 1.56 . . . . 1.8799999999999999 110.437 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.709 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 23.9 t70 65.9 87.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 3.73 110.115 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.863 HG11 ' N ' ' A' ' 31' ' ' HIS . 2.1 t -178.6 179.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 4.1500000000000004 110.192 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.863 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -164.02 94.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 4.3300000000000001 109.907 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.27 -158.88 31.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 1.1599999999999999 109.49 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.7 126.63 5.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.154 . . . . 2.8199999999999998 110.197 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.869 ' HZ3' ' HB3' ' A' ' 21' ' ' PHE . 18.7 m95 -79.9 158.4 26.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.77000000000000002 110.161 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 1.164 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -159.43 127.63 5.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.958 . . . . 3.5600000000000001 110.218 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 1.121 ' O ' ' N ' ' A' ' 38' ' ' GLY . 10.3 mt -54.4 -162.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 1.7 110.095 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' C ' ' O ' ' A' ' 36' ' ' LEU . 2.3 tttm -17.03 -28.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 3.3399999999999999 109.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 1.164 ' C ' ' HD2' ' A' ' 35' ' ' LYS . . . 152.85 33.96 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.549 -1.42 . . . . 1.3799999999999999 109.549 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.845 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -118.03 113.89 37.37 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.279 -1.13 . . . . 3.8799999999999999 110.044 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 87.93 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.906 1.477 . . . . 2.0699999999999998 110.385 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.885 ' H ' HD21 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -70.12 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 3.4500000000000002 109.988 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -167.98 111.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 4.0300000000000002 110.074 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.805 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -37.24 109.93 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 3.4700000000000002 110.264 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.188 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . 45.4 m -129.6 -143.07 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 3.2999999999999998 110.049 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 1.188 ' CD ' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -73.14 -23.19 18.38 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.078 1.567 . . . . 3.3300000000000001 110.141 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.58 6.48 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 2.6000000000000001 110.092 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.805 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 2.8 t -126.91 124.14 38.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 1.8300000000000001 110.026 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.99 87.74 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 2.2799999999999998 110.337 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.63 HG12 HD11 ' A' ' 58' ' ' LEU . 9.7 mt -99.05 114.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 2.5099999999999998 110.305 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.016 ' O ' HG21 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -123.07 103.88 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 2.6000000000000001 109.987 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' HD1' ' A' ' 56' ' ' HIS . 13.1 pt-20 -127.03 134.53 50.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 2.21 110.289 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.43 26.24 10.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 2.8399999999999999 110.125 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 1.151 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 85.61 -111.97 3.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.923 -1.271 . . . . 1.3400000000000001 109.923 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.624 ' C ' ' O ' ' A' ' 53' ' ' GLY . 1.1 pttt -26.5 -11.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.522 -0.987 . . . . 3.4399999999999999 110.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 1.151 ' N ' ' O ' ' A' ' 53' ' ' GLY . 3.2 mmtt -148.28 154.75 40.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 2.98 110.555 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.779 ' CD2' HD13 ' A' ' 25' ' ' LEU . 87.3 m-70 -137.29 122.0 18.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.395 -0.816 . . . . 0.69999999999999996 109.808 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.18 132.99 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.015 . . . . 2.04 110.536 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.786 HD22 ' HD2' ' A' ' 21' ' ' PHE . 7.6 tp -110.29 153.24 25.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 1.77 109.907 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.478 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 84.9 mt -147.48 86.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 1.8300000000000001 110.319 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.96 HD23 ' CE ' ' A' ' 67' ' ' MET . 2.4 mt -85.36 135.37 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 1.52 110.14 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 63' ' ' CYS . 66.6 m-70 -98.15 -165.48 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 1.1499999999999999 110.464 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 1.179 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -14.55 79.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 2.7200000000000002 110.535 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.856 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 7.7 m -76.15 134.35 39.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.72999999999999998 110.11 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.019 ' O ' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -75.79 -173.15 2.14 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.307 -0.871 . . . . 2.7799999999999998 111.277 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.151 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.2 tp -76.64 -33.27 58.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.538 -0.726 . . . . 2.1200000000000001 110.037 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 1.047 ' O ' ' N ' ' A' ' 68' ' ' THR . . . -52.92 -51.68 44.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.298 -1.521 . . . . 1.3500000000000001 109.298 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.96 ' CE ' HD23 ' A' ' 60' ' ' LEU . 16.2 mtt -36.44 -0.05 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.428 -1.042 . . . . 1.8100000000000001 110.263 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 1.151 ' OG1' ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.36 80.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 1.6699999999999999 110.193 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.86 -139.9 2.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.698 -1.361 . . . . 0.92000000000000004 109.698 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.44 145.95 51.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -1.106 . . . . 2.0800000000000001 110.044 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' HD11 ' A' ' 8' ' ' LEU . 3.7 t -90.98 94.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 1.22 110.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.7 p -96.43 110.47 22.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 1.29 110.213 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.552 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 37.4 t80 -85.85 151.69 23.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 2.1499999999999999 110.049 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -132.6 131.8 41.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 2.8599999999999999 110.238 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 76' ' ' ALA . . . -160.88 131.83 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 1.75 110.281 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 75' ' ' ALA . . . 39.32 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 1.5900000000000001 110.368 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.718 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -122.67 2.24 9.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 2.0099999999999998 110.407 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.726 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -85.02 157.98 20.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.933 . . . . 1.8500000000000001 110.053 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -159.91 112.51 2.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 3.7400000000000002 110.272 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.776 ' HG ' ' CD1' ' A' ' 8' ' ' LEU . 79.6 p -107.44 173.39 6.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 1.75 110.046 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -165.3 100.18 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 1.1299999999999999 110.362 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HB3' ' N ' ' A' ' 9' ' ' TYR . . . -100.19 -174.6 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 1.22 110.247 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.906 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 4.1 m-20 -116.75 132.73 56.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 2.6499999999999999 110.077 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 11' ' ' VAL . 47.5 tp -138.65 131.44 29.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 1.77 110.405 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -131.44 130.58 42.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 3.2999999999999998 110.048 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 1.064 HG13 ' HA ' ' A' ' 65' ' ' LEU . 5.1 t -95.94 112.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 1.1799999999999999 110.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.79 144.72 27.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 2.8300000000000001 110.257 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.738 ' HG3' ' CD1' ' A' ' 65' ' ' LEU . 41.9 mt-10 -81.53 179.28 7.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 2.6800000000000002 110.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.968 -1.015 . . . . 2.7599999999999998 110.192 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.184 0.516 . . . . 2.67 110.164 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.048 HG22 ' CB ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -122.29 -177.72 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 2.83 110.172 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -132.92 -161.33 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 3.8 110.285 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 78' ' ' ALA . 28.5 t -122.67 91.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 1.04 110.196 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 2.2 mm-40 -56.25 -34.53 66.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.269 -0.895 . . . . 2.42 110.363 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -130.82 113.76 16.43 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 2.76 110.264 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.55 -176.01 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.557 . . . . 0.65 110.407 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.982 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 27.5 mt -86.35 -169.34 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.66 110.359 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.982 ' HD1' ' O ' ' A' ' 8' ' ' LEU . 2.9 m-85 -146.99 127.93 14.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 4.53 110.336 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.923 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.96 127.76 33.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.407 -1.477 . . . . 0.8 109.407 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 84' ' ' LEU . 4.0 p -132.5 151.6 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 1.46 110.424 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -104.03 161.08 14.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 2.33 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -156.14 146.64 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.352 -0.842 . . . . 1.65 110.299 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.778 ' HB2' ' OE1' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -97.9 74.88 2.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 1.64 110.211 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.765 ' O ' ' O ' ' A' ' 14' ' ' PHE . 85.6 t 22.15 107.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 1.26 110.12 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.966 ' HA2' ' HB2' ' A' ' 62' ' ' ASN . . . 118.51 -38.69 2.8 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.698 -1.361 . . . . 1.04 109.698 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.778 ' OE1' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -59.66 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 2.49 110.164 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -147.0 117.23 7.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 1.26 110.204 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 161.97 24.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.74 110.027 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.92 131.87 31.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 2.52 110.598 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.926 ' HD2' HD23 ' A' ' 58' ' ' LEU . 84.2 m-85 -136.62 116.79 13.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 1.4 110.056 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -113.12 159.18 19.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.213 -0.929 . . . . 2.06 110.679 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 23' ' ' ILE . 4.6 tt -169.74 119.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.65 110.039 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.675 ' OE2' ' HE2' ' A' ' 55' ' ' LYS . 2.1 tt0 -97.68 143.46 28.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 2.38 110.441 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 56' ' ' HIS . 17.3 mt -105.34 -146.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 1.31 110.101 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 1.048 ' CB ' HG22 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -125.47 -35.51 2.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.45 110.326 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.613 ' HG3' ' CG2' ' A' ' 2' ' ' ILE . 46.5 mt-10 -123.75 136.34 27.24 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 3.06 110.352 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 45.0 Cg_endo -73.64 -173.94 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.063 1.56 . . . . 1.62 110.437 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 1.12 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.9 t70 65.9 87.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 3.73 110.115 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.12 HG23 ' O ' ' A' ' 29' ' ' ASP . 2.1 t -178.6 179.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 3.7 110.192 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.725 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -164.02 94.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 3.64 109.907 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.27 -158.88 31.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.84 109.49 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.7 126.63 5.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.154 . . . . 2.38 110.197 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.887 ' HZ3' ' HB3' ' A' ' 21' ' ' PHE . 18.7 m95 -79.9 158.4 26.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.77 110.161 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.152 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -159.43 127.63 5.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.958 . . . . 3.08 110.218 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.121 ' O ' ' N ' ' A' ' 38' ' ' GLY . 10.3 mt -54.4 -162.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 1.1 110.095 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' C ' ' O ' ' A' ' 36' ' ' LEU . 2.3 tttm -17.03 -28.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 2.88 109.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 1.152 ' C ' ' HD2' ' A' ' 35' ' ' LYS . . . 152.85 33.96 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.549 -1.42 . . . . 1.37 109.549 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.853 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -118.03 113.89 37.37 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.279 -1.13 . . . . 3.59 110.044 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 87.93 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.906 1.477 . . . . 1.83 110.385 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.025 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -70.12 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 2.9 109.988 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -167.98 111.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 3.51 110.074 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -37.24 109.93 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 3.09 110.264 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.191 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . 45.4 m -129.6 -143.07 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.92 110.049 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 1.191 ' CD ' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -73.14 -23.19 18.38 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.078 1.567 . . . . 2.85 110.141 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.58 6.48 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 2.6 110.092 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 2.8 t -126.91 124.14 38.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 1.34 110.026 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.99 87.74 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 2.19 110.337 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.726 HG12 HD12 ' A' ' 58' ' ' LEU . 9.7 mt -99.05 114.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 1.92 110.305 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.834 ' O ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -123.07 103.88 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 2.18 109.987 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 13.1 pt-20 -127.03 134.53 50.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 2.21 110.289 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.43 26.24 10.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 2.84 110.125 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 1.151 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 85.61 -111.97 3.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.923 -1.271 . . . . 1.27 109.923 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.624 ' C ' ' O ' ' A' ' 53' ' ' GLY . 1.1 pttt -26.5 -11.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.522 -0.987 . . . . 3.02 110.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 1.151 ' N ' ' O ' ' A' ' 53' ' ' GLY . 3.2 mmtt -148.28 154.75 40.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 2.57 110.555 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.3 m-70 -137.29 122.0 18.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.395 -0.816 . . . . 0.58 109.808 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.18 132.99 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.015 . . . . 1.45 110.536 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.926 HD23 ' HD2' ' A' ' 21' ' ' PHE . 7.6 tp -110.29 153.24 25.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 1.09 109.907 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 84.9 mt -147.48 86.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 1.13 110.319 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.889 HD22 ' CE ' ' A' ' 67' ' ' MET . 2.4 mt -85.36 135.37 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.95 110.14 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 63' ' ' CYS . 66.6 m-70 -98.15 -165.48 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 1.02 110.464 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 1.179 ' OD1' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -14.55 79.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 2.46 110.535 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.851 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 7.7 m -76.15 134.35 39.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.73 110.11 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.17 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -75.79 -173.15 2.14 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.307 -0.871 . . . . 2.48 111.277 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.151 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.2 tp -76.64 -33.27 58.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.538 -0.726 . . . . 1.63 110.037 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.047 ' O ' ' N ' ' A' ' 68' ' ' THR . . . -52.92 -51.68 44.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.298 -1.521 . . . . 1.35 109.298 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.889 ' CE ' HD22 ' A' ' 60' ' ' LEU . 16.2 mtt -36.44 -0.05 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.428 -1.042 . . . . 1.23 110.263 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 1.151 ' OG1' ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.36 80.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 1.06 110.193 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.86 -139.9 2.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.698 -1.361 . . . . 0.64 109.698 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.44 145.95 51.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -1.106 . . . . 2.08 110.044 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 8' ' ' LEU . 3.7 t -90.98 94.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.57 110.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.7 p -96.43 110.47 22.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.98 110.213 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 37.4 t80 -85.85 151.69 23.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 1.26 110.049 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -132.6 131.8 41.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 2.39 110.238 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 76' ' ' ALA . . . -160.88 131.83 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 1.75 110.281 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 75' ' ' ALA . . . 39.32 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 1.41 110.368 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.718 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -122.67 2.24 9.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 1.72 110.407 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -85.02 157.98 20.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.933 . . . . 1.34 110.053 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -159.91 112.51 2.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 3.35 110.272 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 8' ' ' LEU . 79.6 p -107.44 173.39 6.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 1.22 110.046 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -165.3 100.18 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.48 110.362 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.19 -174.6 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.42 110.247 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.923 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 4.1 m-20 -116.75 132.73 56.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 2.15 110.077 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 11' ' ' VAL . 47.5 tp -138.65 131.44 29.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 1.19 110.405 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -131.44 130.58 42.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 2.93 110.048 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 1.17 HG11 ' O ' ' A' ' 64' ' ' GLN . 5.1 t -95.94 112.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.66 110.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.79 144.72 27.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 2.39 110.257 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG3' ' CD1' ' A' ' 65' ' ' LEU . 41.9 mt-10 -81.53 179.28 7.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 2.68 110.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.968 -1.015 . . . . 2.29 110.192 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.184 0.516 . . . . 2.6699999999999999 110.164 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.048 HG22 ' CB ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -122.29 -177.72 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 2.8300000000000001 110.172 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -132.92 -161.33 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 3.7999999999999998 110.285 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 78' ' ' ALA . 28.5 t -122.67 91.42 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 1.04 110.196 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 2.2 mm-40 -56.25 -34.53 66.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.269 -0.895 . . . . 2.4199999999999999 110.363 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -130.82 113.76 16.43 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 2.7599999999999998 110.264 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.55 -176.01 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.059 1.557 . . . . 0.65000000000000002 110.407 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.982 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 27.5 mt -86.35 -169.34 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.66000000000000003 110.359 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.982 ' HD1' ' O ' ' A' ' 8' ' ' LEU . 2.9 m-85 -146.99 127.93 14.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 4.5300000000000002 110.336 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.923 ' HA2' ' O ' ' A' ' 83' ' ' ASN . . . -64.96 127.76 33.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.407 -1.477 . . . . 0.80000000000000004 109.407 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 84' ' ' LEU . 4.0 p -132.5 151.6 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 1.46 110.424 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -104.03 161.08 14.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 2.3300000000000001 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -156.14 146.64 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.352 -0.842 . . . . 1.6499999999999999 110.299 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.778 ' HB2' ' OE1' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -97.9 74.88 2.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 1.6399999999999999 110.211 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.765 ' O ' ' O ' ' A' ' 14' ' ' PHE . 85.6 t 22.15 107.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 1.26 110.12 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.966 ' HA2' ' HB2' ' A' ' 62' ' ' ASN . . . 118.51 -38.69 2.8 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.698 -1.361 . . . . 1.04 109.698 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.778 ' OE1' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -59.66 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 2.4900000000000002 110.164 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -147.0 117.23 7.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 1.26 110.204 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.25 161.97 24.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.73999999999999999 110.027 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.92 131.87 31.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 2.52 110.598 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.926 ' HD2' HD23 ' A' ' 58' ' ' LEU . 84.2 m-85 -136.62 116.79 13.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 1.3999999999999999 110.056 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -113.12 159.18 19.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.213 -0.929 . . . . 2.0600000000000001 110.679 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 23' ' ' ILE . 4.6 tt -169.74 119.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.65000000000000002 110.039 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.675 ' OE2' ' HE2' ' A' ' 55' ' ' LYS . 2.1 tt0 -97.68 143.46 28.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 2.3799999999999999 110.441 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 56' ' ' HIS . 17.3 mt -105.34 -146.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 1.3100000000000001 110.101 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 1.048 ' CB ' HG22 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -125.47 -35.51 2.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.45 110.326 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.613 ' HG3' ' CG2' ' A' ' 2' ' ' ILE . 46.5 mt-10 -123.75 136.34 27.24 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 3.0600000000000001 110.352 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 45.0 Cg_endo -73.64 -173.94 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.063 1.56 . . . . 1.6200000000000001 110.437 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 1.12 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.9 t70 65.9 87.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 3.73 110.115 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.12 HG23 ' O ' ' A' ' 29' ' ' ASP . 2.1 t -178.6 179.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 3.7000000000000002 110.192 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.725 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -164.02 94.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 3.6400000000000001 109.907 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.27 -158.88 31.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.83999999999999997 109.49 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -158.7 126.63 5.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.154 . . . . 2.3799999999999999 110.197 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.887 ' HZ3' ' HB3' ' A' ' 21' ' ' PHE . 18.7 m95 -79.9 158.4 26.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.77000000000000002 110.161 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.152 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -159.43 127.63 5.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.958 . . . . 3.0800000000000001 110.218 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.121 ' O ' ' N ' ' A' ' 38' ' ' GLY . 10.3 mt -54.4 -162.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -0.901 . . . . 1.1000000000000001 110.095 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' C ' ' O ' ' A' ' 36' ' ' LEU . 2.3 tttm -17.03 -28.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 2.8799999999999999 109.913 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 1.152 ' C ' ' HD2' ' A' ' 35' ' ' LYS . . . 152.85 33.96 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.549 -1.42 . . . . 1.3700000000000001 109.549 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.853 ' N ' ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -118.03 113.89 37.37 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.279 -1.13 . . . . 3.5899999999999999 110.044 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 87.93 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.906 1.477 . . . . 1.8300000000000001 110.385 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.025 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -70.12 -129.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 2.8999999999999999 109.988 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -167.98 111.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 3.5099999999999998 110.074 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' CYS . . . -37.24 109.93 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 3.0899999999999999 110.264 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.191 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . 45.4 m -129.6 -143.07 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.9199999999999999 110.049 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 1.191 ' CD ' ' HB3' ' A' ' 44' ' ' SER . 46.7 Cg_endo -73.14 -23.19 18.38 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.078 1.567 . . . . 2.8500000000000001 110.141 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.58 6.48 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 2.6000000000000001 110.092 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 2.8 t -126.91 124.14 38.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 1.3400000000000001 110.026 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.99 87.74 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 2.1899999999999999 110.337 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.726 HG12 HD12 ' A' ' 58' ' ' LEU . 9.7 mt -99.05 114.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 1.9199999999999999 110.305 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -123.07 103.88 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 2.1800000000000002 109.987 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 13.1 pt-20 -127.03 134.53 50.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 2.21 110.289 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.43 26.24 10.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 2.8399999999999999 110.125 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 1.151 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 85.61 -111.97 3.63 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.923 -1.271 . . . . 1.27 109.923 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.624 ' C ' ' O ' ' A' ' 53' ' ' GLY . 1.1 pttt -26.5 -11.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.522 -0.987 . . . . 3.02 110.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 1.151 ' N ' ' O ' ' A' ' 53' ' ' GLY . 3.2 mmtt -148.28 154.75 40.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 2.5699999999999998 110.555 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.584 ' CD2' HD11 ' A' ' 25' ' ' LEU . 87.3 m-70 -137.29 122.0 18.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.395 -0.816 . . . . 0.57999999999999996 109.808 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.18 132.99 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.015 . . . . 1.45 110.536 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.926 HD23 ' HD2' ' A' ' 21' ' ' PHE . 7.6 tp -110.29 153.24 25.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 1.0900000000000001 109.907 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 84.9 mt -147.48 86.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 1.1299999999999999 110.319 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.889 HD22 ' CE ' ' A' ' 67' ' ' MET . 2.4 mt -85.36 135.37 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.94999999999999996 110.14 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 63' ' ' CYS . 66.6 m-70 -98.15 -165.48 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 1.02 110.464 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 1.179 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -14.55 79.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 2.46 110.535 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.851 ' HB3' ' SD ' ' A' ' 67' ' ' MET . 7.7 m -76.15 134.35 39.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.72999999999999998 110.11 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.17 ' O ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -75.79 -173.15 2.14 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.307 -0.871 . . . . 2.48 111.277 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.151 ' O ' ' OG1' ' A' ' 68' ' ' THR . 2.2 tp -76.64 -33.27 58.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.538 -0.726 . . . . 1.6299999999999999 110.037 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.047 ' O ' ' N ' ' A' ' 68' ' ' THR . . . -52.92 -51.68 44.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.298 -1.521 . . . . 1.3500000000000001 109.298 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.889 ' CE ' HD22 ' A' ' 60' ' ' LEU . 16.2 mtt -36.44 -0.05 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.428 -1.042 . . . . 1.23 110.263 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 1.151 ' OG1' ' O ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.36 80.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.193 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.86 -139.9 2.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.698 -1.361 . . . . 0.64000000000000001 109.698 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.44 145.95 51.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -1.106 . . . . 2.0800000000000001 110.044 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 8' ' ' LEU . 3.7 t -90.98 94.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.56999999999999995 110.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.7 p -96.43 110.47 22.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.97999999999999998 110.213 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 37.4 t80 -85.85 151.69 23.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 1.26 110.049 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -132.6 131.8 41.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 2.3900000000000001 110.238 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 76' ' ' ALA . . . -160.88 131.83 5.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 1.75 110.281 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 75' ' ' ALA . . . 39.32 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 110.368 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.718 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -122.67 2.24 9.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 1.72 110.407 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -85.02 157.98 20.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.933 . . . . 1.3400000000000001 110.053 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -159.91 112.51 2.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 3.3500000000000001 110.272 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 8' ' ' LEU . 79.6 p -107.44 173.39 6.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 1.22 110.046 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -165.3 100.18 0.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.47999999999999998 110.362 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . . . -100.19 -174.6 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.41999999999999998 110.247 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.923 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 4.1 m-20 -116.75 132.73 56.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 2.1499999999999999 110.077 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 11' ' ' VAL . 47.5 tp -138.65 131.44 29.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 1.1899999999999999 110.405 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -131.44 130.58 42.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 2.9300000000000002 110.048 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 1.17 HG11 ' O ' ' A' ' 64' ' ' GLN . 5.1 t -95.94 112.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.66000000000000003 110.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.79 144.72 27.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 2.3900000000000001 110.257 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG3' ' CD1' ' A' ' 65' ' ' LEU . 41.9 mt-10 -81.53 179.28 7.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 2.6800000000000002 110.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.968 -1.015 . . . . 2.29 110.192 179.994 . . . . . . . . 1 1 . 1 stop_ save_